...4D Pharma began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate oral Thetanix in about...
...patients will receive twice-daily Thetanix over 7.5 days. 4D Pharma plc (LSE:DDDD), Manchester, U.K. Product: Thetanix...

...million ($2.1 million). 4d pharma now owns 83.5% of GT Biologics. GT Biologics’ lead product, Thetanix...

...GT Biologics said FDA granted Orphan Drug designation to Thetanix to treat pediatric Crohn's disease (CD...
...of healthy individuals -- is in preclinical testing. GT Biologics Ltd. , Aberdeen, U.K. Product: Thetanix...